News

09
Jun

Beta Cell Technologies project could eliminate the need for injections for type 1 diabetes

Beta Cell Technologies project could eliminate the need for injections for type 1 diabetes

The Beta Cell Technologies project; a recent SAECF grant recipient, was highlighted on Nine News. The project is developing a novel ectopic skin pancreas that could eliminate the need for injections in patients with type 1 diabetes.

View the news story below.

 

 

 

 

Back to News

TechInSA works closely with the hi-tech industry to bring innovative South Australian products and technologies to global markets.
Tweets
TechInSA @TechInSA5
Will the convergence of tech like AI, robotics & data analytics with traditional medtech disrupt healthcare as we k… https://t.co/3tlzSKZoty
TechInSA @TechInSA5
Excited to see @TechInSA5 's @halliday_judy fireside chat on sources of clinician led innovation. Frontline healthc… https://t.co/RLxM71IFXD
TechInSA @TechInSA5
Medtech preclinical strategy of 3 Aussie companies working with innovative pathology, imaging & ingestible connect… https://t.co/SKMr3D5YeB
Processing...
Thank you! Your subscription has been confirmed. You'll hear from us soon.
Sign up to our eNewsletter
Subscribe to our e-Newsletter today to stay up-to-date on the latest hi-tech sector news.
ErrorHere